Fortress Biotech, Inc. (FBIO) › Cash & EquivalentsFortress Biotech, Inc. (FBIO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2006: $02008: $7.0K2009: $1.51M2010: $14.86M2011: $23.16M2012: $40.20M2013: $99.52M2014: $49.76M2015: $98.18M2016: $88.29M2017: $94.95M2018: $65.51M2019: $136.86M2020: $233.35M2021: $305.74M2022: $178.27M2023: $80.93M2024: $57.26M2025: $79.38M$79.38M2006Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$79.38M+38.6%2024$57.26M-29.2%2023$80.93M-54.6%2022$178.27M-41.7%2021$305.74M+31.0%2020$233.35M+70.5%2019$136.86M+108.9%2018$65.51M-31.0%2017$94.95M+7.5%2016$88.29M-10.1%2015$98.18M+97.3%2014$49.76M-50.0%2013$99.52M+147.6%2012$40.20M+73.6%2011$23.16M+55.8%2010$14.86M+884.2%2009$1.51M+21471.4%2008$7.0K—2006$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share